Skip to main content
Erschienen in: Journal of Neurology 6/2015

01.06.2015 | Original Communication

Alcohol responsiveness in laryngeal dystonia: a survey study

verfasst von: Diana N. Kirke, Steven J. Frucht, Kristina Simonyan

Erschienen in: Journal of Neurology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Laryngeal dystonia (LD) is a task-specific focal dystonia of unknown pathophysiology affecting speech production. We examined the demographics of anecdotally reported alcohol use and its effects on LD symptoms using an online survey based on Research Electronic Data Capture (REDCap™) and National Spasmodic Dysphonia Association’s patient registry. From 641 participants, 531 were selected for data analysis, and 110 were excluded because of unconfirmed diagnosis. A total of 406 patients (76.5 %) had LD and 125 (23.5 %) had LD and voice tremor (LD/VT). The consumption of alcohol was reported by 374 LD (92.1 %) and 109 LD/VT (87.2 %) patients. Improvement of voice symptoms after alcohol ingestion was noted by 227 LD (55.9 % of all patients) and 73 LD/VT (58.4 %), which paralleled the improvement observed by patient’s family and/or friends in 214 LD (57.2 %) and 69 LD/VT (63.3 %) patients. The benefits lasted 1–3 h in both groups with the maximum effect after 2 drinks in LD patients (p = 0.002), whereas LD/VT symptoms improved independent of the consumed amount (p = 0.48). Our data suggest that isolated dystonic symptoms, such as in LD, are responsive to alcohol intake and this responsiveness is not attributed to the presence of VT, which is known to have significant benefits from alcohol ingestion. Alcohol may modulate the pathophysiological mechanisms underlying abnormal neurotransmission of γ-aminobutyric acid (GABA) in dystonia and as such provide new avenues for novel therapeutic options in these patients.
Literatur
1.
Zurück zum Zitat (2010) Dietary guidelines for Americans. In: Agriculture UDo, Services UDoHaH (eds) US Government Printing Office, Washington, DC (2010) Dietary guidelines for Americans. In: Agriculture UDo, Services UDoHaH (eds) US Government Printing Office, Washington, DC
2.
Zurück zum Zitat Ali SO, Thomassen M, Schulz GM, Hosey LA, Varga M, Ludlow CL, Braun AR (2006) Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215O PET study. J Speech Lang Hear Res 49:1127–1146CrossRefPubMed Ali SO, Thomassen M, Schulz GM, Hosey LA, Varga M, Ludlow CL, Braun AR (2006) Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215O PET study. J Speech Lang Hear Res 49:1127–1146CrossRefPubMed
3.
Zurück zum Zitat Asgeirsson H, Jakobsson F, Hjaltason H, Jonsdottir H, Sveinbjornsdottir S (2006) Prevalence study of primary dystonia in Iceland. Mov Disord 21:293–298CrossRefPubMed Asgeirsson H, Jakobsson F, Hjaltason H, Jonsdottir H, Sveinbjornsdottir S (2006) Prevalence study of primary dystonia in Iceland. Mov Disord 21:293–298CrossRefPubMed
4.
Zurück zum Zitat Baylor CR, Yorkston KM, Eadie TL, Maronian NC (2007) The psychosocial consequences of BOTOX injections for spasmodic dysphonia: a qualitative study of patients’ experiences. J Voice 21:231–247PubMedCentralCrossRefPubMed Baylor CR, Yorkston KM, Eadie TL, Maronian NC (2007) The psychosocial consequences of BOTOX injections for spasmodic dysphonia: a qualitative study of patients’ experiences. J Voice 21:231–247PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Blitzer A (2010) Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Eur J Neurol 17(Suppl 1):28–30CrossRefPubMed Blitzer A (2010) Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Eur J Neurol 17(Suppl 1):28–30CrossRefPubMed
7.
Zurück zum Zitat Blitzer A, Brin MF, Stewart CF (1998) Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 108:1435–1441CrossRefPubMed Blitzer A, Brin MF, Stewart CF (1998) Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 108:1435–1441CrossRefPubMed
8.
Zurück zum Zitat Boecker H, Wills AJ, Ceballos-Baumann A, Samuel M, Thompson PD, Findley LJ, Brooks DJ (1996) The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study. Ann Neurol 39:650–658CrossRefPubMed Boecker H, Wills AJ, Ceballos-Baumann A, Samuel M, Thompson PD, Findley LJ, Brooks DJ (1996) The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study. Ann Neurol 39:650–658CrossRefPubMed
9.
Zurück zum Zitat Borges V, Ferraz HB, de Andrade LA (2000) Alcohol-sensitive hereditary essential myoclonus with dystonia: a study of 6 Brazilian patients. Neurol Sci 21:373–377CrossRefPubMed Borges V, Ferraz HB, de Andrade LA (2000) Alcohol-sensitive hereditary essential myoclonus with dystonia: a study of 6 Brazilian patients. Neurol Sci 21:373–377CrossRefPubMed
10.
Zurück zum Zitat Brin MF, Blitzer A, Stewart C (1998) Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Adv Neurol 78:237–252PubMed Brin MF, Blitzer A, Stewart C (1998) Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Adv Neurol 78:237–252PubMed
11.
Zurück zum Zitat de Yebenes JG, Vazquez A, Martinez A, Mena MA, del Rio RM, de Felipe C, del Rio J (1988) Biochemical findings in symptomatic dystonias. Adv Neurol 50:167–175PubMed de Yebenes JG, Vazquez A, Martinez A, Mena MA, del Rio RM, de Felipe C, del Rio J (1988) Biochemical findings in symptomatic dystonias. Adv Neurol 50:167–175PubMed
12.
Zurück zum Zitat Deuschl G, Wenzelburger R, Loffler K, Raethjen J, Stolze H (2000) Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor. Brain 123(Pt 8):1568–1580CrossRefPubMed Deuschl G, Wenzelburger R, Loffler K, Raethjen J, Stolze H (2000) Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor. Brain 123(Pt 8):1568–1580CrossRefPubMed
13.
Zurück zum Zitat Frucht SJ, Bordelon Y, Houghton WH, Reardan D (2005) A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Mov Disord 20:1330–1337CrossRefPubMed Frucht SJ, Bordelon Y, Houghton WH, Reardan D (2005) A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Mov Disord 20:1330–1337CrossRefPubMed
14.
Zurück zum Zitat Garibotto V, Romito LM, Elia AE, Soliveri P, Panzacchi A, Carpinelli A, Tinazzi M, Albanese A, Perani D (2011) In vivo evidence for GABA(A) receptor changes in the sensorimotor system in primary dystonia. Mov Disord 26:852–857CrossRefPubMed Garibotto V, Romito LM, Elia AE, Soliveri P, Panzacchi A, Carpinelli A, Tinazzi M, Albanese A, Perani D (2011) In vivo evidence for GABA(A) receptor changes in the sensorimotor system in primary dystonia. Mov Disord 26:852–857CrossRefPubMed
15.
Zurück zum Zitat Gasser T, Bereznai B, Muller B, Pruszak-Seel R, Damrich R, Deuschl G, Oertel WH (1996) Linkage studies in alcohol-responsive myoclonic dystonia. Mov Disord 11:363–370CrossRefPubMed Gasser T, Bereznai B, Muller B, Pruszak-Seel R, Damrich R, Deuschl G, Oertel WH (1996) Linkage studies in alcohol-responsive myoclonic dystonia. Mov Disord 11:363–370CrossRefPubMed
16.
Zurück zum Zitat Gudin M, Vaamonde J, Rodriguez M, Obeso JA (1993) Alcohol sensitive dystonia. Mov Disord 8:122–123CrossRefPubMed Gudin M, Vaamonde J, Rodriguez M, Obeso JA (1993) Alcohol sensitive dystonia. Mov Disord 8:122–123CrossRefPubMed
17.
Zurück zum Zitat Gurey LE, Sinclair CF, Blitzer A (2013) A new paradigm for the management of essential vocal tremor with botulinum toxin. Laryngoscope 123:2497–2501PubMed Gurey LE, Sinclair CF, Blitzer A (2013) A new paradigm for the management of essential vocal tremor with botulinum toxin. Laryngoscope 123:2497–2501PubMed
18.
Zurück zum Zitat Harris P, Taylor R, Theilke R, Payne J, Gonzalez N, Conde J (2009) Research electronic data capture (REDCap)—a metadata driven methodology for providing translational research informatics support. J Biomed Inform 42:377–381PubMedCentralCrossRefPubMed Harris P, Taylor R, Theilke R, Payne J, Gonzalez N, Conde J (2009) Research electronic data capture (REDCap)—a metadata driven methodology for providing translational research informatics support. J Biomed Inform 42:377–381PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Haslinger B, Erhard P, Dresel C, Castrop F, Roettinger M, Ceballos-Baumann AO (2005) “Silent event-related” fMRI reveals reduced sensorimotor activation in laryngeal dystonia. Neurology 65:1562–1569CrossRefPubMed Haslinger B, Erhard P, Dresel C, Castrop F, Roettinger M, Ceballos-Baumann AO (2005) “Silent event-related” fMRI reveals reduced sensorimotor activation in laryngeal dystonia. Neurology 65:1562–1569CrossRefPubMed
20.
Zurück zum Zitat Haubenberger D, McCrossin G, Lungu C, Considine E, Toro C, Nahab FB, Auh S, Buchwald P, Grimes GJ, Starling J, Potti G, Scheider L, Kalowitz D, Bowen D, Carnie A, Hallett M (2013) Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study. Neurology 80:933–940PubMedCentralCrossRefPubMed Haubenberger D, McCrossin G, Lungu C, Considine E, Toro C, Nahab FB, Auh S, Buchwald P, Grimes GJ, Starling J, Potti G, Scheider L, Kalowitz D, Bowen D, Carnie A, Hallett M (2013) Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study. Neurology 80:933–940PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Hedrich K, Meyer EM, Schule B, Kock N, de Carvalho Aguiar P, Wiegers K, Koelman JH, Garrels J, Durr R, Liu L, Schwinger E, Ozelius LJ, Landwehrmeyer B, Stoessl AJ, Tijssen MA, Klein C (2004) Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE mutations. Neurology 62:1229–1231CrossRefPubMed Hedrich K, Meyer EM, Schule B, Kock N, de Carvalho Aguiar P, Wiegers K, Koelman JH, Garrels J, Durr R, Liu L, Schwinger E, Ozelius LJ, Landwehrmeyer B, Stoessl AJ, Tijssen MA, Klein C (2004) Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE mutations. Neurology 62:1229–1231CrossRefPubMed
22.
Zurück zum Zitat Hess C, Saunders-Pullman R (2006) Movement disorders and alcohol misuse. Addict Biol 11:117–125CrossRefPubMed Hess C, Saunders-Pullman R (2006) Movement disorders and alcohol misuse. Addict Biol 11:117–125CrossRefPubMed
23.
Zurück zum Zitat Izdebski K, Dedo HH, Boles L (1984) Spastic dysphonia: a patient profile of 200 cases. Am J Otolaryngol 5:7–14CrossRefPubMed Izdebski K, Dedo HH, Boles L (1984) Spastic dysphonia: a patient profile of 200 cases. Am J Otolaryngol 5:7–14CrossRefPubMed
24.
Zurück zum Zitat Koller WC, Busenbark K, Miner K (1994) The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group. Ann Neurol 35:717–723 Koller WC, Busenbark K, Miner K (1994) The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group. Ann Neurol 35:717–723
25.
Zurück zum Zitat Kyllerman M, Forsgren L, Sanner G, Holmgren G, Wahlstrom J, Drugge U (1990) Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. Mov Disord 5:270–279CrossRefPubMed Kyllerman M, Forsgren L, Sanner G, Holmgren G, Wahlstrom J, Drugge U (1990) Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. Mov Disord 5:270–279CrossRefPubMed
26.
27.
Zurück zum Zitat Lim SC, Kim JS, An JY, Yoon Kang S (2012) Alcohol-responsive writer’s cramp. Intern Med 51:99–101CrossRefPubMed Lim SC, Kim JS, An JY, Yoon Kang S (2012) Alcohol-responsive writer’s cramp. Intern Med 51:99–101CrossRefPubMed
28.
Zurück zum Zitat Lof E, Ericson M, Stomberg R, Soderpalm B (2007) Characterization of ethanol-induced dopamine elevation in the rat nucleus accumbens. Eur J Pharmacol 555:148–155CrossRefPubMed Lof E, Ericson M, Stomberg R, Soderpalm B (2007) Characterization of ethanol-induced dopamine elevation in the rat nucleus accumbens. Eur J Pharmacol 555:148–155CrossRefPubMed
29.
Zurück zum Zitat Lou JS, Jankovic J (1991) Essential tremor: clinical correlates in 350 patients. Neurology 41:234–238CrossRefPubMed Lou JS, Jankovic J (1991) Essential tremor: clinical correlates in 350 patients. Neurology 41:234–238CrossRefPubMed
30.
Zurück zum Zitat Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB, Hallett M, Jinnah HA, Juergens U, Martin SB, Perlmutter JS, Sapienza C, Singleton A, Tanner CM, Woodson GE (2008) Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg 139:495–505PubMedCentralCrossRefPubMed Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB, Hallett M, Jinnah HA, Juergens U, Martin SB, Perlmutter JS, Sapienza C, Singleton A, Tanner CM, Woodson GE (2008) Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg 139:495–505PubMedCentralCrossRefPubMed
31.
32.
Zurück zum Zitat Marjanska M, Lehericy S, Valabregue R, Popa T, Worbe Y, Russo M, Auerbach EJ, Grabli D, Bonnet C, Gallea C, Coudert M, Yahia-Cherif L, Vidailhet M, Meunier S (2013) Brain dynamic neurochemical changes in dystonic patients: a magnetic resonance spectroscopy study. Mov Disord 28:201–209PubMedCentralCrossRefPubMed Marjanska M, Lehericy S, Valabregue R, Popa T, Worbe Y, Russo M, Auerbach EJ, Grabli D, Bonnet C, Gallea C, Coudert M, Yahia-Cherif L, Vidailhet M, Meunier S (2013) Brain dynamic neurochemical changes in dystonic patients: a magnetic resonance spectroscopy study. Mov Disord 28:201–209PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Meyer TK, Hu A, Hillel AD (2013) Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin. Laryngoscope 123(Suppl 6):S1–S14CrossRefPubMed Meyer TK, Hu A, Hillel AD (2013) Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin. Laryngoscope 123(Suppl 6):S1–S14CrossRefPubMed
34.
Zurück zum Zitat Mubaidin AF (2000) Alcohol with xylocaine for treatment of eyelid dystonia. Eur J Neurol 7:213–215CrossRefPubMed Mubaidin AF (2000) Alcohol with xylocaine for treatment of eyelid dystonia. Eur J Neurol 7:213–215CrossRefPubMed
35.
Zurück zum Zitat Nestoros JN (1980) Ethanol specifically potentiates GABA-mediated neurotransmission in feline cerebral cortex. Science 209:708–710CrossRefPubMed Nestoros JN (1980) Ethanol specifically potentiates GABA-mediated neurotransmission in feline cerebral cortex. Science 209:708–710CrossRefPubMed
36.
Zurück zum Zitat Novakovic D, Waters HH, D’Elia JB, Blitzer A (2011) Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes. Laryngoscope 121:606–612CrossRefPubMed Novakovic D, Waters HH, D’Elia JB, Blitzer A (2011) Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes. Laryngoscope 121:606–612CrossRefPubMed
37.
38.
Zurück zum Zitat Ridding MC, Sheean G, Rothwell JC, Inzelberg R, Kujirai T (1995) Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia. J Neurol Neurosurg Psychiatry 59:493–498PubMedCentralCrossRefPubMed Ridding MC, Sheean G, Rothwell JC, Inzelberg R, Kujirai T (1995) Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia. J Neurol Neurosurg Psychiatry 59:493–498PubMedCentralCrossRefPubMed
39.
Zurück zum Zitat Schweinfurth JM, Billante M, Courey M (2002) Risk factors and demographics in patients With spasmodic dysphonia. Laryngoscope 112:220–223CrossRefPubMed Schweinfurth JM, Billante M, Courey M (2002) Risk factors and demographics in patients With spasmodic dysphonia. Laryngoscope 112:220–223CrossRefPubMed
40.
Zurück zum Zitat Simonyan K, Berman BD, Herscovitch P, Hallett M (2013) Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia. J Neurosci 33:14705–14714PubMedCentralCrossRefPubMed Simonyan K, Berman BD, Herscovitch P, Hallett M (2013) Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia. J Neurosci 33:14705–14714PubMedCentralCrossRefPubMed
41.
Zurück zum Zitat Simonyan K, Frucht SJ (2013) Long-term effect of sodium oxybate (Xyrem®) in spasmodic dysphonia with vocal tremor. Tremor Other Hyperkinet Mov (N Y) Simonyan K, Frucht SJ (2013) Long-term effect of sodium oxybate (Xyrem®) in spasmodic dysphonia with vocal tremor. Tremor Other Hyperkinet Mov (N Y)
42.
Zurück zum Zitat Simonyan K, Ludlow CL (2010) Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study. Cereb Cortex 20:2749–2759PubMedCentralCrossRefPubMed Simonyan K, Ludlow CL (2010) Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study. Cereb Cortex 20:2749–2759PubMedCentralCrossRefPubMed
44.
Zurück zum Zitat Simonyan K, Tovar-Moll F, Ostuni J, Hallett M, Kalasinsky VF, Lewin-Smith MR, Rushing EJ, Vortmeyer AO, Ludlow CL (2008) Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study. Brain 131:447–459PubMedCentralCrossRefPubMed Simonyan K, Tovar-Moll F, Ostuni J, Hallett M, Kalasinsky VF, Lewin-Smith MR, Rushing EJ, Vortmeyer AO, Ludlow CL (2008) Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study. Brain 131:447–459PubMedCentralCrossRefPubMed
45.
Zurück zum Zitat Sulica L, Louis ED (2010) Clinical characteristics of essential voice tremor: a study of 34 cases. Laryngoscope 120:516–528CrossRefPubMed Sulica L, Louis ED (2010) Clinical characteristics of essential voice tremor: a study of 34 cases. Laryngoscope 120:516–528CrossRefPubMed
46.
Zurück zum Zitat Valente EM, Misbahuddin A, Brancati F, Placzek MR, Garavaglia B, Salvi S, Nemeth A, Shaw-Smith C, Nardocci N, Bentivoglio AR, Berardelli A, Eleopra R, Dallapiccola B, Warner TT (2003) Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov Disord 18:1047–1051CrossRefPubMed Valente EM, Misbahuddin A, Brancati F, Placzek MR, Garavaglia B, Salvi S, Nemeth A, Shaw-Smith C, Nardocci N, Bentivoglio AR, Berardelli A, Eleopra R, Dallapiccola B, Warner TT (2003) Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov Disord 18:1047–1051CrossRefPubMed
47.
Zurück zum Zitat White LJ, Klein AM, Hapner ER, Delgaudio JM, Hanfelt JJ, Jinnah HA, Johns MM 3rd (2011) Coprevalence of tremor with spasmodic dysphonia: a case-control study. Laryngoscope 121:1752–1755PubMedCentralCrossRefPubMed White LJ, Klein AM, Hapner ER, Delgaudio JM, Hanfelt JJ, Jinnah HA, Johns MM 3rd (2011) Coprevalence of tremor with spasmodic dysphonia: a case-control study. Laryngoscope 121:1752–1755PubMedCentralCrossRefPubMed
48.
Zurück zum Zitat Ziemann U, Lonnecker S, Paulus W (1995) Inhibition of human motor cortex by ethanol. A transcranial magnetic stimulation study. Brain 118(Pt 6):1437–1446PubMed Ziemann U, Lonnecker S, Paulus W (1995) Inhibition of human motor cortex by ethanol. A transcranial magnetic stimulation study. Brain 118(Pt 6):1437–1446PubMed
Metadaten
Titel
Alcohol responsiveness in laryngeal dystonia: a survey study
verfasst von
Diana N. Kirke
Steven J. Frucht
Kristina Simonyan
Publikationsdatum
01.06.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 6/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7751-2

Weitere Artikel der Ausgabe 6/2015

Journal of Neurology 6/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.